Co-Authors
This is a "connection" page, showing publications co-authored by Tianlei Ying and Yanling Wu.
Connection Strength
4.289
-
Identification of Human Single-Domain Antibodies against SARS-CoV-2. Cell Host Microbe. 2020 06 10; 27(6):891-898.e5.
Score: 0.882
-
Single-Domain Antibodies As Therapeutics against Human Viral Diseases. Front Immunol. 2017; 8:1802.
Score: 0.746
-
Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III. Emerg Microbes Infect. 2017 Oct 11; 6(10):e89.
Score: 0.737
-
Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy. Antib Ther. 2021 Apr; 4(2):89-98.
Score: 0.236
-
The impact of receptor-binding domain natural mutations on antibody recognition of SARS-CoV-2. Signal Transduct Target Ther. 2021 03 23; 6(1):132.
Score: 0.234
-
Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerg Microbes Infect. 2020; 9(1):382-385.
Score: 0.217
-
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV. Antibodies (Basel). 2019 Nov 04; 8(4).
Score: 0.213
-
In-Depth Analysis of Human Neonatal and Adult IgM Antibody Repertoires. Front Immunol. 2018; 9:128.
Score: 0.188
-
Engineered Soluble Monomeric IgG1 Fc with Significantly Decreased Non-Specific Binding. Front Immunol. 2017; 8:1545.
Score: 0.185
-
A Potent Germline-like Human Monoclonal Antibody Targets a pH-Sensitive Epitope on H7N9 Influenza Hemagglutinin. Cell Host Microbe. 2017 Oct 11; 22(4):471-483.e5.
Score: 0.184
-
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD. Cell Rep. 2021 02 02; 34(5):108699.
Score: 0.058
-
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response. Signal Transduct Target Ther. 2020 11 27; 5(1):282.
Score: 0.057
-
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients. Cell Mol Immunol. 2020 10; 17(10):1095-1097.
Score: 0.056
-
Human-IgG-Neutralizing Monoclonal Antibodies Block the SARS-CoV-2 Infection. Cell Rep. 2020 07 21; 32(3):107918.
Score: 0.056
-
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein. Cell Mol Immunol. 2020 07; 17(7):765-767.
Score: 0.054
-
A defucosylated bispecific multivalent molecule exhibits broad HIV-1-neutralizing activity and enhanced antibody-dependent cellular cytotoxicity against reactivated HIV-1 latently infected cells. AIDS. 2018 08 24; 32(13):1749-1761.
Score: 0.049
-
Potent In Vivo NK Cell-Mediated Elimination of HIV-1-Infected Cells Mobilized by a gp120-Bispecific and Hexavalent Broadly Neutralizing Fusion Protein. J Virol. 2017 10 15; 91(20).
Score: 0.046
-
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected Cells. Sci Rep. 2017 08 22; 7(1):9130.
Score: 0.046
-
Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy. Sci Rep. 2017 07 24; 7(1):6222.
Score: 0.045